Matt Hiller > DLA Piper LLP (US) > New York, United States > Lawyer Profile

DLA Piper LLP (US)
1251 AVENUE OF THE AMERICAS
NEW YORK, NY 10020-1104
United States
Matt Hiller photo

Work Department

Litigation, Arbitration and Investigations

Position

Partner

Career

Matt Hiller is an experienced investigator and trial lawyer who represents clients in white collar, cyber and corporate investigations and complex litigation. A former federal prosecutor, he has led significant and sophisticated criminal and national security investigations and litigation, and consulted for state and federal law enforcement and other governmental agencies across the United States and abroad regarding cyber investigative techniques.

Before joining the Department of Justice, Matt was an associate at DLA Piper, handling complex commercial litigation and white-collar investigations, and serving on Senator George J. Mitchell’s independent investigation into alleged illegal use of steroids and other performance-enhancing substances in Major League Baseball.

Education

J.D., University of Illinois College of Law; B.A., University of Missouri – Columbia

Lawyer Rankings

United States > Dispute resolution > Corporate investigations and white-collar criminal defense

The team at DLA Piper LLP (US) is able to draw on the firm’s global network to handle government investigations and enforcement matters involving multiple jurisdictions. In 2018, the Dallas office was joined by Jason Hopkins and Jason Lewis from Greenberg Traurig LLPJoel Athey joined in Los Angeles from Holland & Knight LLPJeffrey Tsai joined in San Francisco from Alston & Bird LLP and the Chicago office welcomed Matt Hiller from the DOJ. Highlights for Washington DC’s John Rah included assisting Pfizer with the negotiation of a Corporate Integrity Agreement with the DOJ to resolve allegations that donations the client made to independent charity patient assistant programs were improper. In another standout matter, New York’s Karl Buch represented the Audit Committee of Cognizant Technology Solutions, successfully convincing the DOJ to decline charges following an investigation into potential FCPA violations; in a parallel case, he secured a settlement with the SEC in administrative proceedings. Gail Rodgers is engaged by GlaxoSmithKline on a number of government and internal investigations. The team is chaired by Jonathan King in Chicago and John Hillebrecht in New York; Jessica Masella in New York is also a name to note.